Peter Byeff

Affiliations
  • Cancer Center of Central Connecticut, Southington, CT, USA.

Publications (1)

Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma.

Leukemia & lymphoma
Avec: Katja Weisel , Meletios Dimopoulos , Philippe Moreau , Munci Yagci , Alessandra Larocca , Abraham S Kanate , Filiz Vural , Nicola Cascavilla , Supratik Basu , Peter Johnson , Peter Byeff , Marek Hus , Paula Rodríguez-Otero , Ercan Muelduer , Pekka Anttila , Patrick J Hayden , Maria-Theresa Krauth , Paulo Lucio , Dina Ben-Yehuda , Larisa Mendeleeva , Shien Guo , Xin Yu , Lara Grote , Tsvetan Biyukov , Sujith Dhanasiri , Paul Richardson

Réseau de co-auteurs

Katja Weisel 1 collaboration
Meletios Dimopoulos 1 collaboration
Philippe Moreau 1 collaboration
Munci Yagci 1 collaboration
Alessandra Larocca 1 collaboration
Abraham S Kanate 1 collaboration
Filiz Vural 1 collaboration
Nicola Cascavilla 1 collaboration
Supratik Basu 1 collaboration
Peter Johnson 1 collaboration
Marek Hus 1 collaboration
Paula Rodríguez-Otero 1 collaboration
Ercan Muelduer 1 collaboration
Pekka Anttila 1 collaboration
Patrick J Hayden 1 collaboration
Maria-Theresa Krauth 1 collaboration
Paulo Lucio 1 collaboration
Dina Ben-Yehuda 1 collaboration
Larisa Mendeleeva 1 collaboration
Shien Guo 1 collaboration
Xin Yu 1 collaboration
Lara Grote 1 collaboration
Tsvetan Biyukov 1 collaboration
Sujith Dhanasiri 1 collaboration
Paul Richardson 1 collaboration